Biocorrx Stock Price, News & Analysis
Company Description
Biocorrx (OTC Link: BICX) is a publicly traded medical care facilities company in the Healthcare sector. The company has a market capitalization of $9.5M.
BICX stock has declined 19.7% over the past year. Shares last traded at $0.4000.
On a trailing twelve-month basis, Biocorrx reported revenue of $797K with net income of -$3.4M and diluted earnings per share of $-0.19. The company operates at a net profit margin of -431.5%.
This page provides a comprehensive overview of BICX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biocorrx (BICX) stock last traded at $0.4000. Over the past 12 months, the stock has lost 19.7%. At a market capitalization of $9.5M, BICX is classified as a micro-cap stock with approximately 26.4M shares outstanding.
Latest News
Biocorrx has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, fda approval, clinical trial. View all BICX news →
SEC Filings
Biocorrx has filed 3 recent SEC filings, including 1 Form 8-K, 1 Form 10-K, 1 Form 10-Q. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BICX SEC filings →
Financial Highlights
Biocorrx generated $797K in revenue over the trailing twelve months, operating income reached -$4.8M (-606.0% operating margin), and net income was -$3.4M, reflecting a -431.5% net profit margin. Diluted earnings per share stood at $-0.19. The company generated -$2.3M in operating cash flow. With a current ratio of 0.10, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Biocorrx (BICX) currently stands at 11.8 thousand shares, up 173.7% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 155.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Biocorrx (BICX) currently stands at 2.4 days, up 144% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 95.2% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 21.1 days.
BICX Company Profile & Sector Positioning
Biocorrx (BICX) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BICX often look at related companies in the same sector, including Veltex (VLXC), Xcelerate Inc (XCRT), Aesthetic Medical International Holdings Group Ltd (PAIYY), Numinus Wellness Inc. (NUMIF), and Selectis Health Inc (GBCS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BICX's relative position within its industry.